This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
COTY Inks Agreement to Offload 3.6% of Its Stake in Wella
by Zacks Equity Research
COTY inks a letter of intent to divest part of its stake in Wella to IGF Wealth Management. This is likely to help the company meet its leverage goal toward 3X as it exits CY23.
Are Investors Undervaluing Nu Skin Enterprises (NUS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Helen of Troy (HELE) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 19.75% and 2.46%, respectively, for the quarter ended May 2023. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin (NUS) Down 12.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nu Skin (NUS) Q1 Earnings & Revenues Top Estimates, Dip Y/Y
by Zacks Equity Research
Nu Skin's (NUS) first-quarter 2023 results reflect difficult year-over-year comparisons and macroeconomic hurdles. However, a focus on the Nu Vision 2025 strategy has been working well.
Nu Skin Enterprises (NUS) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 12.12% and 0.92%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
AB InBev (BUD) to Report Q1 Earnings: What's on the Cards?
by Zacks Equity Research
AB InBev's (BUD) Q1 results are expected to reflect gains from premiumization efforts, expansion of the beyond beer portfolio and digital initiatives, offset by elevated costs and currency headwinds.
Factors Influencing Monster Beverage's (MNST) Q1 Earnings
by Zacks Equity Research
Monster Beverage (MNST) Q1 results are expected to reflect gains from the solid energy drinks business, continued pricing actions and product innovation. However, cost inflation has been concerning.
Factors to Consider Ahead of Nu Skin's (NUS) Q1 Earnings
by Zacks Equity Research
Nu Skin's (NUS) first-quarter performance is likely to reflect macro headwinds like prolonged COVID-related disruptions, unfavorable currency rates and global inflation.
Is Nu Skin Enterprises (NUS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Nu Skin Enterprises (NUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Beats on Q3 Earnings and Sales, Ups View
by Zacks Equity Research
Procter & Gamble's (PG) Q3 results benefit from robust pricing and a favorable mix, along with strength across its segments.
e.l.f. Beauty (ELF) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
e.l.f. Beauty (ELF) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Nu Skin's (NUS) Nu Vision 2025 Strategy Bodes Well, Costs Hurt
by Zacks Equity Research
Nu Skin (NUS) benefits from its product launches and Nu Vision 2025 strategy amid challenges like cost inflation and currency volatility.
Nu Skin (NUS) Hurt by Cost Inflation, Adverse Currency Movements
by Zacks Equity Research
Nu Skin (NUS) bears the brunt of COVID-related disruptions, unfavorable currency movements and global inflation.
Why Is Nu Skin (NUS) Down 9.2% Since Last Earnings Report?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Estee Lauder Companies Inc. (EL) Online Sales Aid Growth
by Zacks Equity Research
The Estee Lauder Companies Inc. (EL) is benefiting from a strong online business. It has a solid presence in emerging markets, which bodes well.
Nu Skin (NUS) Q4 Earnings Top Estimates, Sales Down Y/Y
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter 2022 results reflect lower revenues and earnings on macro headwinds, continued inflation and unfavorable currency.
Nu Skin Enterprises (NUS) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 67.92% and 3.94%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin (NUS) Readies for Q4 Earnings: Everything to Note
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter results are likely to reflect the adverse impacts of cost inflation and currency translations, whereas a focus on the Nu Vision 2025 strategy is likely to have been an upside.
Service Corporation (SCI) Queued for Q4 Earnings: Things to Note
by Zacks Equity Research
Service Corporation's (SCI) fourth-quarter 2022 performance will likely reflect the adverse impact of rising inflationary pressure. Rising corporate general and administrative costs are a concern.
Factors to Watch Ahead of Kraft Heinz's (KHC) Q4 Earnings
by Zacks Equity Research
Kraft Heinz's (KHC) fourth-quarter results are likely to reflect gains from pricing actions and a focus on the operating model amid cost and supply-chain concerns.
Nu Skin Enterprises (NUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kellogg (K) Set to Report Q4 Earnings: What Should You Know?
by Zacks Equity Research
Kellogg's (K) fourth-quarter results are likely to reflect strength in the snacks business and emerging markets, whereas cost inflation is likely to have been a concern.
Helen of Troy (HELE) Soars 5.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Helen of Troy (HELE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.